Navigation Links
New angel capital centered on GenTel agreement with big pharma

Madison, Wis. - GenTel BioSciences, a privately-held biotechnology company, has completed what it calls a critical round of financing activity by raising an additional $500,000 to pursue a new partnership with a large pharmaceutical company.

Alex Vodenlich, president and CEO of GenTel, said the identity of the pharma company would not be anno......

Full article >>> gov/Act255">Act 255, the state's investment tax credit program, and Wisconsin Investment Partners, a Madison-based angel investment network that emphasizes life-science investments.

"They [GenTel] have had good marketplace acceptance and nice sales growth, albeit for a young company," said Dick Leazer, a princi......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 02/20/07


Related biology technology :

1. Investor warns of angel-venture funding gap
2. Breaking down Wisconsins angel capital numbers
3. Research explains why women lack equal access to angel capital
4. Capital-raising term sheets for angels and venture capitalists
5. National angel investment grew 11 percent in `06
6. BioSystem Development secures angel funding
7. New Silicon Pastures director envisions more home cooking for Wisconsin angels
8. Milwaukee angel network invests in St. Louis company
9. Small Tree receives additional angel funding
10. Burke would like to double Act 255 angel tax credits
11. Midwest plays small role in VC investment, angel groups to the rescue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... of the QB3@953 life sciences incubator to ... health. The shared laboratory space at QB3@953 was created ... a key obstacle for many early stage organizations - ... of the sponsorship, Amgen launched two "Amgen Golden Ticket" ...
Breaking Biology Technology:
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):